The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Actinogen Medical (ASX:ACW) is developing a promising oral treatment for Alzheimer’s and depression and is accelerating clinical trials with new capital.

CEO Steven Gourlay, joins The Market Online to discuss the company’s development.

Join the discussion: See what HotCopper users are saying about Actinogen Medical Ltd and be part of the conversations that move the markets.

acw by the numbers
More From The Market Online
The Market Online Video

Australian Gold and Copper: Maiden resource complete, growth story continues

HotCopper talks to AGC MD Glen Diemar as precious and critical metals explorer Australian Gold and…
The Market Online Video

HotCopper Highlights, Week 8: Zip unfastened; Coles in trouble, BHP’s India pivot & more

Good Afternoon and welcome to the latest edition of HotCopper Highlights where we go through the stocks and announcements you were watching this week on

Temas Resources hunting for REEs in historic core

Temas Resources is examining 181 historic holes for iron, titanium, vanadium, chromium, gallium, scandium and other…

Eclipse Metals obtains promising Grønnedal metallurgical results

Eclipse Metals has reported encouraging preliminary Phase 1 metallurgical results from the Grønnedal rare earth element…